***PLEASE NOTE: Guidance is being issued by SPS recommending extended monitoring intervals for medication issued under a shared-care agreement during the COVID-19 NHS response - MLCSU reviewed and locally adapted versions of this guidance can be accessed here: MLCSU Central COVID-19 resource page. Please check back regularly for updates***
**Please note — Morecambe Bay CCG have agreed to the Atypical Antipsychotic Shared Care Guidelines for use in patients that fall under LCFT; for patients in South Cumbria the Cumbria Shared Care Guidelines should be followed
**Please note — For Blackpool, Fylde & Wyre CCG DMARD Shared Care Guidelines please use the versions available on the CCG website
Methylphenidate, Lisdexamfetamine, Dexamfetamine, Atomoxetine - For Attention Deficit Hyperactivity Disorder in adults aged over 17 years and in children and adolescents aged 6 to 17 years
Guanfacine - For Attention Deficit Hyperactivity Disorder in children and adolescents aged 6 to 17 years
Amisulpride, Aripiprazole, Olanzapine, Quetiapine, Oral Risperidone
This shared prescribing guideline for the second-generation antipsychotic medications listed above has been developed with due consideration to the appropriate NICE Clinical Guidelines (CG) e.g. Bipolar Disorder (CG185), Psychosis and Schizophrenia in Children and Young People (CG155), Psychosis and Schizophrenia in Adults (CG178), Schizophrenia- Aripiprazole (TA213), Bipolar Disorder- Adolescents (TA292).